Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
- PMID: 9339933
- PMCID: PMC1191021
- DOI: 10.1097/00000658-199709000-00006
Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
Abstract
Background and objective: The sentinel node hypothesis assumes that a primary tumor drains to a specific lymph node in the regional lymphatic basin. To determine whether the sentinel node is indeed the node most likely to harbor an axillary metastasis from breast carcinoma, the authors used cytokeratin immunohistochemical staining (IHC) to examine both sentinel and nonsentinel lymph nodes.
Methods: From February 1994 through October 1995, patients with breast cancer were staged with sentinel lymphadenectomy followed by completion level I and II axillary dissection. If the sentinel node was free of metastasis by hematoxylin and eosin staining (H&E), then sentinel and nonsentinel nodes were examined with IHC.
Results: The 103 patients had a median age of 55 years and a median tumor size of 1.8 cm (58.3% T1, 39.8% T2, and 1.9% T3). A mean of 2 sentinel (range, 1-8) and 18.9 nonsentinel (range, 7-37) nodes were excised per patient. The H&E identified 33 patients (32%) with a sentinel lymph node metastasis and 70 patients (68%) with tumor-free sentinel nodes. Applying IHC to the 157 tumor-free sentinel nodes in these 70 patients showed an additional 10 tumor-involved nodes, each in a different patient. Thus, 10 (14.3%) of 70 patients who were tumor-free by H&E actually were sentinel node-positive, and the IHC lymph node conversion rate from sentinel node-negative to sentinel node-positive was 6.4% (10/157). Overall, sentinel node metastases were detected in 43 (41.8%) of 103 patients. In the 60 patients whose sentinel nodes were metastasis-free by H&E and IHC, 1087 nonsentinel nodes were examined at 2 levels by IHC and only 1 additional tumor-positive lymph node was identified. Therefore, one H&E sentinel node-negative patient (1.7%) was actually node-positive (p < 0.0001), and the nonsentinel IHC lymph node conversion rate was 0.09% (1/1087; p < 0.0001).
Conclusions: If the sentinel node is tumor-free by both H&E and IHC, then the probability of nonsentinel node involvement is <0.1%. The true false-negative rate of this technique using multiple sections and IHC to examine all nonsentinel nodes for metastasis is 0.97% (1/103) in the authors' hands. The sentinel lymph node is indeed the most likely axillary node to harbor metastatic breast carcinoma.
Similar articles
-
Histopathologic analysis of sentinel lymph nodes in breast carcinoma.Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):744-50. Zhonghua Yi Xue Za Zhi (Taipei). 2000. PMID: 11076431
-
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?Ann Surg. 1999 Apr;229(4):536-41. doi: 10.1097/00000658-199904000-00013. Ann Surg. 1999. PMID: 10203087 Free PMC article.
-
Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.Cancer. 2000 Mar 1;88(5):1099-107. Cancer. 2000. PMID: 10699901
-
Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401. doi: 10.1097/00000658-199509000-00016. Ann Surg. 1995. PMID: 7677468 Free PMC article. Review.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
Cited by
-
Analysis of factors related to N2- or N3-stage breast cancer associated with 1-2 positive sentinel lymph nodes in Chinese patients.Transl Cancer Res. 2020 Apr;9(4):2249-2258. doi: 10.21037/tcr.2020.03.28. Transl Cancer Res. 2020. PMID: 35117585 Free PMC article.
-
Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells.Cancer Sci. 2008 Mar;99(3):441-50. doi: 10.1111/j.1349-7006.2007.00672.x. Epub 2007 Dec 7. Cancer Sci. 2008. PMID: 18070155 Free PMC article. Review.
-
Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.Am J Pathol. 2007 Feb;170(2):774-86. doi: 10.2353/ajpath.2007.060761. Am J Pathol. 2007. PMID: 17255343 Free PMC article.
-
Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer.Ann Surg. 2001 Jul;234(1):79-84. doi: 10.1097/00000658-200107000-00012. Ann Surg. 2001. PMID: 11420486 Free PMC article.
-
Lymphatic Drainage Mapping with Indirect Lymphography for Canine Mammary Tumors.Animals (Basel). 2021 Apr 13;11(4):1115. doi: 10.3390/ani11041115. Animals (Basel). 2021. PMID: 33924625 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical